Target Name: LIX1-AS1
NCBI ID: G101926893
Review Report on LIX1-AS1 Target / Biomarker Content of Review Report on LIX1-AS1 Target / Biomarker
LIX1-AS1
Other Name(s): LIX1 and RIOK2 antisense RNA 1, transcript variant X14 | LIX1 and RIOK2 antisense RNA 1 | LIX1-AS1 variant X14

LIX1-AS1: A Potential Drug Target and Biomarker

LIX1-AS1 is a non-coding RNA molecule that has been identified as an antisense RNA 1 in the LIX1 gene, which is located on chromosome 6p11.2. LIX1 is a key regulator of microRNA (miRNA) expression and has been involved in the regulation of various cellular processes, including cell growth, differentiation, and programmed cell death. LIX1-AS1 has been shown to play a critical role in the regulation of these processes and is currently considered as a potential drug target and biomarker.

Antisense RNA 1 (AS1)

AS1 is a class of non-coding RNAs that can interact with specific miRNAs and cause them to be cleaved, leading to changes in miRNA levels and stability. LIX1 is known to regulate the levels of AS1 and other ASes, including AS1. The AS1-miRNA interaction is a critical mechanism for the regulation of miRNA expression and has been implicated in various cellular processes, including cell growth, differentiation, and programmed cell death.

Transcript Variant X14

LIX1-AS1 has several transcript variants, including transcript variant X14. X14 is a widely expressed transcript variant that is predominantly expressed in the brain and other organ tissues. The levels of X14 expression have been shown to be regulated by LIX1, and studies have suggested that it may play a role in the regulation of various cellular processes, including brain development and function.

Drug Target Potential

The potential drug target for LIX1-AS1 is due to its involvement in the regulation of miRNA expression and its role in the regulation of cellular processes. LIX1 has been shown to play a critical role in the regulation of miRNA expression and has been implicated in the regulation of various cellular processes, including cell growth, differentiation, and programmed cell death. As such, LIX1-AS1 may be a potential drug target for the treatment of various diseases.

Biomarker Potential

The potential biomarker for LIX1-AS1 is its ability to interact with specific miRNAs and cause them to be cleaved. This interaction can be used to measure the levels of LIX1-AS1 in a given sample and to monitor the effects of a drug on LIX1-AS1 levels. The levels of LIX1-AS1 have been shown to be regulated by various factors, including LIX1 itself, and the levels of LIX1-AS1 have been used as a biomarker for the treatment of various diseases.

Conclusion

LIX1-AS1 is a non-coding RNA molecule that has been identified as an antisense RNA 1 in the LIX1 gene. It has been shown to play a critical role in the regulation of miRNA expression and has been implicated in various cellular processes, including cell growth, differentiation, and programmed cell death. As such, LIX1-AS1 may be a potential drug target and biomarker. Further studies are needed to fully understand the role of LIX1-AS1 in cellular processes and its potential as a drug target.

Protein Name: LIX1 And RIOK2 Antisense RNA 1

The "LIX1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LIX1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LIX1L | LKAAEAR1 | LKB1-LIP1-SMAD4 complex | LL22NC03-63E9.3 | LLCFC1 | LLGL1 | LLGL2 | LLPH | LMAN1 | LMAN1L | LMAN2 | LMAN2L | LMBR1 | LMBR1L | LMBRD1 | LMBRD2 | LMCD1 | LMCD1-AS1 | LMF1 | LMF2 | LMLN | LMNA | LMNB1 | LMNB2 | LMNTD1 | LMNTD2 | LMNTD2-AS1 | LMO1 | LMO2 | LMO3 | LMO4 | LMO7 | LMO7-AS1 | LMO7DN | LMOD1 | LMOD2 | LMOD3 | LMTK2 | LMTK3 | LMX1A | LMX1B | LMX1B-DT | LNC-LBCS | LNCAROD | LNCARSR | LNCATV | LNCNEF | LNCOC1 | LNCOG | LNCPRESS1 | LNCRI | LNCRNA-ATB | LNCRNA-IUR | LNCTAM34A | LNP1 | LNPEP | LNPK | LNX1 | LNX1-AS1 | LNX2 | LOC100127946 | LOC100127955 | LOC100128002 | LOC100128028 | LOC100128050 | LOC100128059 | LOC100128079 | LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548